Introduction
Macrophages and related cell types 
Lipid measurements
Liquid chromatography/mass spectrometry measurements were performed to measure lipid species following detailed protocols available online:
http://www.lipidmaps.org/protocols/index.html
Immunoblot analysis
The BMDMs were lysed in a buffer containing 20 mM HEPES (pH 7.4), 150 mM NaCl, 10%
glycerol, 1 mM EDTA, 1% TritonX-100, 100 mM NaF, 100 mM Sodium pyrophosphate, 17.5mM
β-glycerophosphate, and 1x complete protease inhibitor cocktail (Roche) and 1x PhosSTOP
Phosphatase inhibitor cocktail (Roche). Each sample (20 mg) was separated by SDS-PAGE and transferred to a polyvinylidene difluoride membrane. The membranes were incubated with anti-eIF2a antibody, anti-phospho-eIF2a antibody,
anti-CHOP antibody (Cell Signaling).
RNA analysis
Total RNA was purified and analyzed by microarray and quantitative PCR as previously described (27 Figure 1A ). The majority of 25OHC dependent changes in CE and sphingolipid levels occurred in BMDMs cultured in both standard 10% serum-containing media and 10% LDS-containing media ( Figure 1A ). 
25OHC induction of stress response genes is independent of LXRs and SREBPs
We next investigated potential roles of One potential mechanism by which GCN2 could recognize increasing oxidative stress would be to recognize a deficiency in intracellular cysteine that develops as levels of glutathione are depleted. Our analysis provides initial evidence suggesting that oxidative stress and/or cysteine limitation is important for 25OHC mediated activation of GCN2. However, additional studies will be needed to determine the exact stress signal to which GCN2 is responding.
Although two recent independent studies demonstrated the broad anti-viral activity of 25OHC, the mechanism by which 25OHC suppresses viral infection is still unclear (11,12,59).
We demonstrate that 25OHC significantly alters important plasma membrane lipid species and activates the ISR both of which may contribute to the anti-viral activity of 25OHC. These studies were primarily supported by NIH grant GM U54 069338 to the LIPID MAPS Consortium. 
